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INTRODUCTION
Aromatic fine chemicals comprise a wide variety of molecules with different applications. Among them are aroma compounds (Etschmann et al. 2002; Hansen et al. 2009 ) for the cosmetic and food industry, drug precursors (DeLoache et al. 2015; Galanie et al. 2015) and compounds exhibiting health benefits, such as flavonoids and stilbenoids Eichenberger et al. 2017; Lehka et al. 2017) . Usually, aromatic chemicals are either produced from petroleum-based feedstocks or extracted from plant materials. Nevertheless, petroleum-based procedures rely on resources which are not renewable and are overall energy expensive processes. Additionally, extraction of pure compounds from plants is a complicated process due to the high diversity of compounds that can be synthesised by a plant. Therefore, purification is difficult to obtain and yields are generally low. In such context, white biotechnology presents several advantages, reducing environmental footprints and facilitating the purification of the desired compound. In particular, Saccharomyces cerevisiae is a widely studied and used host organism to produce relevant aromatic compounds by metabolic engineering of the aromatic amino acid biosynthetic pathway (Suastegui and Shao 2016; Gottardi et al. 2017b) . In fact, this yeast has interesting characteristics that make it suitable for versatile genetic modifications, and exhibits resistance to stressful industrial processes (Weber et al. 2012) .
We have previously shown that engineered S. cerevisiae is able to produce trans-cinnamic acid (tCA) and its derivatives, such as hydrocinnamyl alcohol (HcinOH), via the intermediate cinnamaldehyde (cinALD), as shown in Fig. 1 (Gottardi et al. 2017a) . tCA can be used as a precursor for the chemical synthesis of aroma compounds, exhibits antimicrobial activity and, like HcinOH, it finds applications in the cosmetic industry due to its sweet aroma. tCA and HcinOH can be produced by extending the L-phenylalanine biosynthetic pathway of yeast via co-expression of an Arabidopsis thaliana phenylalanine ammonia lyase (AtPAL2) enzyme, which allows for the production of tCA, an aryl carboxylic acid reductase (ACAR from Nocardia genus bacteria), together with a phosphopantetheinyl transferase, EntD from Escherichia coli, and endogenous aldehyde Figure 1 . Overview of the heterologous pathway. The reaction scheme for the production of trans-cinnamic acid (tCA) and hydrocinnamyl alcohol (HcinOH) and proposed metabolic pathway for the biosynthesis of cinnamyl methyl ketone is shown. Enzyme names are highlighted in bold. Black lines symbolise known metabolic steps, grey lines symbolise unknown enzymes. Filled lines stand for single enzymatic reactions, dashed lines for multiple steps.
reductases (Gottardi et al. 2017a) . Besides plants and fungi whose metabolic pathways extend from L-phenylalanine to the phenylpropanoid pathway, Photorhabdus luminescens is one of the four bacteria known to encode a PAL (PlStlA), allowing production of tCA from L-phenylalanine (Williams, Thomas and Clarke 2005; Chalabaev et al. 2008) . Here, we decided to compare the previously used plant AtPal2 with the bacterial PAL enzyme, because feedback regulation of AtPal2 might impair its activity (Yin et al. 2012) . In contrast, transcription of the bacterial PAL has been found to be upregulated by its metabolic product tCA (Chalabaev et al. 2008) . This regulatory mechanism would contradict a negative effect of tCA on the activity of the enzyme. Secondly, we investigated the possibility to convert tCA to its glucose ester, cinnamoyl-D-glucose, via the expression of a UDP-glucose:cinnamate glucosyltransferase (FaGT2) (EC 2.4.1.177) from Fragaria x ananassa, strawberry plant, (Lunkenbein et al. 2006) , which could be used to decrease its toxicity to the yeast cells (Hansen et al. 2009 (Hansen et al. : 2765 . Third, the yeast strains were metabolically engineered to rationally increase production of tCA and HcinOH, and possible further bottlenecks were investigated. Finally, we could identify an unknown byproduct of HcinOH production in yeast (Gottardi et al. 2017a) .
MATERIAL AND METHODS

Plasmid and strain construction
Synthetic genes, PlstlA opt (accession number MF622032) and FaGT2 opt (accession number MF622033), used in this study were codon optimised according to the yeast glycolytic codon usage (Wiedemann and Boles 2008) and ordered from GeneART (Thermo Fisher Scientific, Germany). All the plasmids were cloned via Gibson assembly (Gibson et al. 2009 ) or in vivo homologous recombination in yeast (Oldenburg et al. 1997) , by amplifying the DNA fragments of interest with primers carrying about 40 nucleotides long 5´overhangs, homologous to the respective adjacent DNA fragments. Mutated isoforms of ARO4 and ARO7 were generated using primers bearing the mutation of interest. Assembled plasmids are listed in Table 1 . Primers used in this study are listed in supplementary materials (Table S1 , Supporting Information). Escherichia coli strain DH10β was used for subcloning and transformants were selected on lysogeny broth agar plates supplemented with 100 mg/L ampicillin, according to previously described methods (Sambrook and Russel 2001) . Yeast transformations were carried out according to a previously described method (Gietz and Schiestl 2007a,b) . Deletion of ARO10 in S. cerevisiae CEN.PK113-7D was generated by homologous recombination, using a loxP-deletion cassette amplified from pUG6H (Güldener et al. 1996) containing the resistance marker for hygromycin (hphNT1). The loxP-hygromycin cassette was removed by expression of cre recombinase, pNatCre (Steensma and Ter Linde 2001) , generating strain MGY7.
Strains CEN. were genomically engineered in the same way in order to integrate the alleles ARO4 K229L and ARO7 G141S , and they were generated via CRISPR-Cas9-mediated deletion/insertion according to the following procedure. ARO7 was deleted using CRISPR-Cas9-assembled vector (pCC-N-JHV4) (Generoso et al. 2016: 203-5 
Strain cultivations
Strains MGY0.01, MGY0.02, MGY0.03 and MGY0.04 which were used to investigate the best vector for the production of tCA were cultivated on YNB medium, additionally supplemented with 0.1 M phosphate buffer at pH 6.4, 20 g/L D-glucose (SMD2%) and supplemented with 100 mg/L clonNAT/nourseothricin for maintenance of the plasmid. The other cultivations were carried out in synthetic defined medium (Verduyn et al. 1992 ) with 0.1 M potassium phosphate buffer at pH 6.4. D-glucose concentration and initial optical density at 600 nm (OD 600nm ) varied according to the experiment. For high OD fermentations of strains MGY0.07, MGY14.1, MGY17.1, MGY0.08, MGY14.2 and MGY17.2, precultures were grown with 20 g/L D-glucose, and fermentation was set up at initial OD 600nm of 10 and in medium with 50 g/L D-glucose. Precultures and fermentations to determine the influence of the nitrogen source towards PAL activity in strain MGY0.08 were carried out in the same synthetic defined medium with 30 g/L D-glucose and 6 mM ammonium sulphate or 6 mM Lproline as sole nitrogen sources. Initial OD 600nm was set to 0.2. In feeding experiments, precultures of strains MGY0.05, MGY0.06 and MGY0.09 were grown in synthetic minimal medium with 20 g/L D-glucose. For the other cultivations, either 50 g/L Dglucose, pyruvate or ethanol at 0.27 M (equal molar concentration to 50 g/L D-glucose) were used. cinALD was freshly added at final concentrations of 0.68 mM (89.9 mg/L). All precultures were grown until exponential phase and after washing steps, yeast cells were inoculated in fresh medium. All fermentations or feeding experiments were carried out either in 300 mL Erlenmeyer flasks with 50 mL of yeast culture or in 100 mL Erlenmeyer flasks with 20 mL of yeast culture. All the cultivations were performed at 30
• C, shaking at 180 rpm and when necessary, supplemented with antibiotics for maintenance of the plasmids. Experiments were performed in biological duplicates or triplicates, as described in figure legends.
In vitro carboligation reaction and in vivo bioconversion
Pyruvate decarboxylase (Pdc) carboligation reaction between cinALD and active acetaldehyde was performed in 2 mL volume at 30
• C. The buffer, 0.5 M citrate buffer at pH 6, was supplemented with 1 mM thiamine pyrophosphate, 2 mM MgCl 2 , 10 mM pyruvate, 1U Pdc (0.5U/mL) (Sigma-Aldrich, Germany) and 0.68 mM (89.9 mg/L) cinALD (Agarwal et al. 2015) . The reaction was stopped by addition of methanol (400 μL) and samples were centrifuged for 10 min at 16 000× g to pellet Pdc. An aliquot of 500 μL of supernatant was added to 500 μL of S. cerevisiae TAM strain (van Maris et al. 2004) cell suspension (OD 20) in the previously described synthetic defined medium without glucose (supplemented with 0.02 g/L of uracil to complement auxotrophy), to obtain a final OD 600nm of 10 in the mixture. A control experiment was performed in the same culture conditions, by using synthetic defined medium with 50 g/L D-glucose and 0.68 mM cinALD. Cultures of 1 mL volume were incubated for 24 h and samples analysed via high pressure liquid chromatography (HPLC) according to the methods described in the following paragraph.
Growth and metabolite analyses via HPLC
Cell density of collected samples (OD 600nm ) was measured over time in order to monitor cell growth with a spectrophotometer (Ultrospec 2100 pro spectrophotometer, GE Healthcare, USA (Gottardi et al. 2017a) . For quantification of D-glucose, ethanol and pyruvate, culture supernatants were treated with 5-sulphosalicylic acid to a final concentration of 5% [w/v] and run through HPLC (Thermo Fisher Scientific, Germany) equipped with a HyperREZ XP Carbohydrate H + column (300 × 700 mm, 8 micron; Thermo Fisher Scientific, Germany), coupled to a refractive index detector (Shodex RI-101, Shoko Scientific Co., Kanagawa, Japan). The eluent used for separation was 5 mM H 2 SO 4 , column temperature and flow rate were kept constant at 65
• C and 0.6 mL/min, respectively. Data analysis and graphing were carried out using the software Prism 5 (GraphPad, USA).
Mass spectrometry analyses
Analyses for identification of cinnamoyl-D-glucose were performed with an HPLC (Agilent 1100 Series, Agilent Technologies Inc.) equipped with a Luna 3 μm C18(2) column (100Å, 150 × 2 mm) (Phenomenex, Aschaffenburg, Germany) and coupled to a diode array detector G1315B (Agilent) and a mass spectrometer (MS) Bruker Daltonics esquire 3000 plus (Bruker Daltonics, Bremen, Germany). The supernatants of samples were run via the HPLC, kept at 28 • C. Injection volume was 5 μL. The eluent gradient used proceeded from 100% eluent A (H 2 O with 0.1% formic) and 0% eluent B (methanol with 0.1% formic acid) to 50% eluent B acid in 30 min. Eluent B was raised until 100% in the following 5 min and kept constant for 15 min. The gradient was brought back to 100% eluent A in the following 5 min and kept constant for 10 min. The flow rate was kept constant at 0.2 ml/min and cinnamoyl-D-glucose was detected at UV wavelength of 280 nm. Mass data were acquired in negative and positive ionisation modes and ions were fragmented in auto MS 2 mode. Collision gas was helium (3.56 × 10 −6 mbar) with 1 V collision voltage.
Capillary voltage was 4000 V, the end plate was set to -500 V, capillary exit was 121V and the Octopole RF amplitude was 150 Vpp. Nebulizer gas (N 2 ) had a pressure of 35 psi. Dry gas (N 2 ) temperature and flow were 330
• C and 9 L min −1 .
Analyses of UP1 were performed via ultra high pressure liquid chromatography (UHPLC), Dionex Ultimate 3000 (Thermo Fisher Scientific, Germany) coupled to UV/Vis-Detector at 200-600 nm wavelength and to an Impact II mass spectrometer (Bruker Daltonics). The chromatography column used was an Acquity UHPLC BEH C18 1.7 μm RP column (2.1 × 50 mm) (Waters, Germany). The gradient of the eluent used started with 5% acetonitrile with 0.1% formic acid (eluent A) and 95% H 2 O with 0.1% formic acid (eluent B) to 95% eluent A and 5% eluent B in 12 min at a flow rate of 0.4 mL/min. Temperature was kept constant at 40
• C. Samples were prepared as follow: 1 mL of culture supernatants was freeze dried and resuspended in 500 μL methanol, sonicated for 10 min and centrifuged at max speed for 20 min. Supernatants were used for UHPLC-MS/MS analyses.
RESULTS
Comparison of plant AtPAL2 opt and bacterial PlstlA opt for tCA production in yeast First, PAL2 from the plant A. thaliana (AtPAL2), as used in our pioneering work about tCA production in yeast (Gottardi et al. 2017a) , was compared with a bacterial PAL from P. luminescens (PlStlA) in order to test their differences in the production of tCA in S. cerevisiae. It was previously shown that establishing new metabolic pathways in yeast expression of heterologous genes from low copy number plasmids can be advantageous compared to high copy number plasmids (Schadeweg and Boles 2016). Thus, two vector backbones were assessed, a CEN-based low copy number and a 2 micron-based high copy plasmid, both expressing codon-optimised versions of the two genes, AtPAL2 opt or PlstlA opt , each under control of the strong and constitutive HXT7 promoter fragment (Hauf, Zimmermann and Mueller 1999) . Saccharomyces cerevisiae CEN.PK113-7D was transformed with the corresponding plasmids pE-MGV9, pC-MGV12, pC-MGV13 or pE-MGV14 (Table 1) . Transformants were grown until exponential phase, re-inoculated in fresh SMD2% medium, and the production of tCA was followed over 24 h of cultivation (Fig. 2) . For both isoenzymes, expression from high copy plasmids (2μ) resulted in higher tCA production compared to expression from low copy plasmids (CEN). For low copy plasmids, expression of both, AtPAL2 opt and PlstlA opt , allowed for the production of similar tCA titres after 24 h of cultivation (2.7 ± 0.04 and 2.6 ± 0.08 mg/L, respectively). In contrast, when expressed from high copy number plasmids, a higher tCA titre (7.3 ± 0.04 mg/L) was reached with PlstlA opt in comparison to AtPAL2 opt (5.6 ± 0.78 mg/L), indicating that the bacterial enzyme is superior to the plant enzyme in yeast under these conditions (Fig. 2) . In general, it was noted that the production of tCA was generally lower in SMD2% medium compared to the synthetic defined medium used in our previous work (Gottardi et al. 2017a) . Therefore, in the following experiments of this study the synthetic defined medium (Verduyn et al. 1992; Gottardi et al. 2017a) was used again.
Bacterial PAL enzymes could already be successfully expressed in yeast previously (Jendresen et al. 2015) . However, in contrast to some other examples (Schadeweg and Boles 2016), the expression from high copy number plasmids was superior to low copy number plasmids, indicating that the expression level of PAL is a limiting factor in our approach.
Synthesis of cinnamoyl-D-glucose
We also investigated the conversion of tCA into tCA-glucose, cinnamoyl-D-glucose, which can be of interest when tCA is the desired final product. tCA is toxic to yeast cells (Chambel, Viegas and Sa´-Correia 1999; Guo and Olsson 2016; Gottardi et al. 2017a ), but conversion of aromatic compounds into the corresponding glucosides has been proven to reduce toxicity and therefore is a common strategy to improve production without hampering cell fitness (Hansen et al. 2009) .
A UDP-glucose:cinnamate glucosyltransferase (FaGT2) from strawberry, Fragaria x ananassa (Lunkenbein et al. 2006) , was chosen, cloned on a centromeric vector as a codon optimised version (Wiedemann and Boles 2008) under control of the strong pTPI1 promoter (pC MGV15) and transformed into CEN.PK113-7D, resulting in strain MGY0.06. The control strain, named MGY0.05, contained the corresponding empty vector. High cell density (OD 600nm = 10) fermentations were performed in synthetic defined medium with 50 g/L D-glucose and 200 mg/L tCA (Fig. 3) . tCA was partly consumed and at the same time a new compound was found in the culture supernatant whose concentrations increased with decreasing tCA concentrations. Due to the lack of a reference compound for standard quantification only relative amounts could be determined (Fig. 3) . This compound could be identified and characterised as cinnamoyl-D-glucose by liquid chromatography-mass spectrometry (LC-MS) (Lunkenbein et al. 2006 
Optimisation of the biosynthesis pathway for tCA and HcinOH production
As the aromatic amino acid biosynthesis pathway in S. cerevisiae is strongly feedback regulated not only at the transcriptional but also at the enzyme level (Braus 1991; Luttik et al. 2008) , the native ARO4 and ARO7 genes were replaced by genes encoding feedback-resistant isoforms Aro4 K229L and Aro7 G141S (Luttik et al. 2008 ) under control of the strong and constitutive promoters pTPI1 and the truncated pHXT7, respectively, generating strain MGY14. It was previously shown that the deletion of genes encoding decarboxylases catalysing the entry step into the Ehrlich pathway, such as ARO10, increased the production of L-phenylalanine-and L-tyrosine-derived compounds (Koopman et al. 2012; Romagnoli et al. 2012) . Therefore, ARO10 was deleted in strain MGY14, generating strain MGY17. Strains CEN.PK113-7D, MGY14 and MGY17 were transformed with pE-MGV14 (expressing PlstlA opt ), generating strains MGY0.07, MGY14.1 and MGY17.1, respectively, and high OD (OD 600nm = 10) fermentations in synthetic defined medium were analysed for tCA production (Fig. 4A) . The OD values did not vary significantly between the strains during the fermentation. At the end of the cultivation, strain MGY14.1 (overexpressing Aro4 K229L , Aro7 G141S and PlStlA opt ) produced 29.8 ± 1.9 mg/L of tCA, a more than 2-fold increase compared to the parental strain MGY0.07 (overexpressing PlStlA opt ), which produced 13.5 ± 0.4 mg/L tCA. Moreover, strain MGY17.1 (overexpression of Aro4 K229L , Aro7 G141S , PlStlA opt and deletion of ARO10) produced even 37.9 ± 6.5 mg/L tCA, a 3-fold increase compared to the control strain MGY0.07. In order to assess if the deletion of ARO10 reduced the carbon flux towards the competing Ehrlich pathway, 2-phenylethanol production was also followed (Fig. 4B) . Interestingly, whereas the parental strain (MGY0.07) produced only minor amounts of 2-phenylethanol (1.67 ± 0.03 mg/L), upregulation of the aromatic amino acid biosynthesis pathway in MGY14.1 resulted in up to 94.9 ± 1.7 mg/L of 2-phenylethanol. Deletion of ARO10 reduced the production of 2-phenylethanol to 21.6 ± 0.7 mg/L. Concerning the molar concentrations this however means that although 2-phenylethanol production decreased by 0.60 mM from strain MGY14.1 compared to MGY17.1, tCA production increased only by 0.05 mM, indicating either increased production of other compounds derived from phenylpyruvate or regulatory constraints. As tCA has been proven to be toxic to yeast cells (Chambel, Viegas and Sa´-Correia 1999; Guo and Olsson 2016; Gottardi et al. 2017a) , we thought that its toxicity might have impaired overall cell fitness and have contributed to the relatively little increased production rate in MGY17.1. Therefore, we performed the same experiment with the simultaneous overexpression of ACAR opt and EntD opt (pRS41K optACAR optEntD) (Bruder and Boles 2016) in order to convert tCA further into the far less toxic HcinOH (Gottardi et al. 2017a) . Strains MGY0.08, MGY14.2, MGY17.2 (expressing PAL and ACAR opt ) were generated and fermentations were performed. In contrast to tCA, after 24 h of cultivation HcinOH titres exhibited a significant improvement after deletion of ARO10 (Fig. 4C) 212.9 ± 0.4 mg/L of HcinOH. Generally, 2-phenylethanol was produced at lower titres compared to the respective strains without pRS41K optACAR optEntD plasmid, reaching 45.6 ± 4.5 and 16.5 ± 0.3 mg/L in strains MGY14.2 and MGY17.2, respectively (Fig. 4D) . Interestingly, the decrease in 2-phenylethanol production after deletion of ARO10 in molar concentrations (0.24 mM) matched with the increased molar concentration of HcinOH (0.26 mM), indicating that blocking of the Ehrlich pathway can result in the nearly complete channelling of the surplus of carbon into HcinOH. In order to further channel the metabolic flux towards HcinOH, deletions of other decarboxylases involved in the entry step of the Ehrlich pathway, like PDC5, will be of interest.
Optimisation of the HcinOH biosynthesis pathway
Aiming to further improve the production of the fine chemical HcinOH, optimisation of two upstream reactions from the phenylpyruvate branch were investigated. The enzymes involved are Aro8, the transaminase catalysing the conversion of phenylpyruvate to L-phenylalanine Urrestarazu et al. 1998; Bulfer, Brunzelle and Trievel 2013) , and the enzyme PlStlA opt , which deaminates L-phenylalanine to tCA and ammonium (Williams, Thomas and Clarke 2005; Chalabaev et al. 2008; Lango-Scholey et al. 2013) . ARO8 was overexpressed (pE-MGV18) in strain MGY17.2, generating MGY17.3 (overexpression of Aro4 K229L , Aro7 G141S , PlStlA opt , ACAR opt , ARO8 and deletion of ARO10), and production of HcinOH was followed over time in a fermentation. This was done in synthetic defined medium, without or with the addition of 800 mg/L L-glutamate, as L-glutamate acts as an amino donor for the transaminase reaction catalysed by Aro8 . However, neither overexpression of ARO8 nor addition of L-glutamate improved the production of HcinOH: 212.9 ± 0.4 mg/L in MGY17.2, 204.7 ± 9.6 mg/L in MGY17.3 and 194.4 ± 7.5 mg/L in MGY17.3 plus L-glutamate. Subsequently, the PAL reaction was investigated in more detail in order to analyse the possibility of the presence of a bottleneck at this reaction step. PAL converts L-phenylalanine into tCA and NH 4 + . As the medium contains 37 mM ammonium sulphate (Verduyn et al. 1992) , we hypothesised that the chemical equilibrium of the PAL reaction might be shifted towards the substrate, L-phenylalanine, thereby affecting its conversion. Consequently, we performed a low cell density (OD 600nm = 0.2) fermentation with strain MGY0.08 (overexpressing PlStlA opt and ACAR opt only)
in synthetic defined medium with a different nitrogen source, L-proline. In Fig. 5A , the yield of HcinOH per consumed glucose is shown. In the presence of ammonium sulphate, the yield was 2.73 mg HcinOH /g Glu , while in the experimental set up with L-proline as nitrogen source the yield was improved up to 4.07 mg HcinOH /g Glu . To ensure that the change of nitrogen source did not just boost the whole aromatic amino acid pathway, 2-phenylethanol was also quantified, as it is a good indicator of the flux within the pathway (Luttik et al. 2008) . As also the ratio between HcinOH and 2-phenylethanol was higher in the presence of L-proline (23.04 mg HcinOH /mg phenylethanol ) compared to the medium with ammonium sulphate (4.06 mg HcinOH /mg phenylethanol ), this indicates that the positive effect of L-proline versus ammonium sulphate is not due to a general improvement of the aromatic amino acid pathway. The results suggest that ammonium sulphate has a negative impact directly on the PAL reaction, and other nitrogen source such as L-proline can improve the yield of HcinOH. In line with these results, using proline as a sole nitrogen source further increases the performance of the optimised strain MGY17.2 (Fig. 5B) .
Investigations on the production of an unidentified by-product
Our previous experiments showed that co-expression of a PAL enzyme, ACAR opt and EntD opt not only allows the de novo production of HcinOH as end product, via the intermediate cinALD, but also another by-product is synthesised, named as UP1 (Gottardi et al. 2017a) . One possibility could be that such product is derived from cinALD. In fact, cinALD can react with an active acetaldehyde via the carboligation activity of Pdc enzymes, producing 3-hydroxy-5-phenyl-4-penten-2-one, further reduced to (2S,3R)-5-phenylpent-4-ene-2,3-diol ( Fig. 1) (Miyakoshi et al. 2016) . Following this hint, we tried to elucidate how the production of UP1 occurs. High cell density (OD 600nm = 10) feeding experiments with cinALD were performed in different culture media. cinALD was freshly added to yeast cultures in synthetic defined medium containing different carbon sources: 270 mM (50 g/L) D-glucose, .9 mg/L, was also added to a culture of pdc1,5,6 null strain, named TAM, in media with 50 g/L glucose (TAM). An in vitro reaction was performed to obtain the carboligation product between cinALD (89.9 mg/L) and active acetaldehyde (which is formed by PDC from added pyruvate). The in vitro carboligation products were fed to the TAM strain (in vitro + TAM), in media without glucose, and UP1 relative area was quantified as above. Data are expressed as mean values of duplicate experiments and standard error of the mean as error bars.
270 mM pyruvate, 270 mM ethanol or without any carbon source. In order to ensure pyruvate uptake, S. cerevisiae CEN.PK113-7D was transformed with an overexpression vector pRS62N-Jen1 (Generoso et al. 2017) encoding for the yeast lactate/pyruvate transporter Jen1, resulting in strain MGY0.09. Figure 6A shows the production of UP1 in the four different conditions. Interestingly, UP1 is produced only in the presence of glucose, which is converted to pyruvate via glycolysis, or in the presence of pyruvate in the medium. With this experiment we could prove that UP1 is produced from cinALD only under conditions when enough pyruvate is available as the precursor of the Pdc carboligation reaction.
Secondly, an in vitro reaction was set up in order to synthetise the intermediate of the carboligation reaction between cinALD and pyruvate-derived active acetaldehyde catalysed by Pdc (Miyakoshi et al. 2016) . Analysis of the reaction products via HPLC did not show the presence of UP1, but other compounds were detected (data not shown). One explanation could be that UP1 is not the direct product of the carboligase reaction, 3-hydroxy-5-phenyl-4-penten-2-one, but might be derived from it by further metabolic reactions. Thus, we fed the in vitro reaction products to the yeast strain TAM, a pdc1, 5, 6 null strain (van Maris et al. 2004 ) to determine whether 3-hydroxy-5-phenyl-4-penten-2-one could be further converted to UP1. Interestingly, after adding the in vitro reaction products we could observe an increasing area of UP1 within 24 h of cultivation, indicating that the product of the carboligase reaction is further converted to UP1 by unspecified yeast enzymes, in vivo. Interestingly, the control set up, that is the same pdc1, 5, 6 null TAM strain cultivated in the presence of glucose and cinALD at the same initial concentrations present in the in vitro reaction (89.9 mg/L), produced only minor amounts of UP1 (Fig. 6B) , which might be due to the activity of other native decarboxylases with carboligation mechanism, or a different compound might co-elute with UP1. This experiment demonstrates that, although the starting concentration of cinALD was equal in the two experimental set ups, UP1 is significantly produced by the TAM strain only when the carboligation activity happens in vitro, as the pdc1, 5, 6 null TAM strain lacks the main carboligating enzymes.
To further prove that UP1 derives from the carboligation of active acetaldehyde and cinALD, we performed analytical experiments to identify the sum formula of UP1. Strain CEN.PK113-7D bearing an empty vector control (pRS41K; strain MGY1), or expressing ACAR opt and EntD opt , (pRS41K optACAR optEntD; strain MGY2) were cultivated with 50 g/L D-glucose in the presence of tCA or fully deuterated tCA (D 7 -tCA). Also, a control set up without addition of tCA was performed for both strains MGY1 and MGY2. Culture supernatants were analysed via HPLC-MS/MS after 24 h of cultivation (OD 600nm = 10). Such analyses allowed us to detect a compound in the supernatant of MGY2 in the presence of tCA or D 7 -tCA which was not detected in the supernatant of the cultivation set up without tCA and not present in the control experiments with strain MGY1. This compound exhibited a molecular weight of a positively ionised mass of m/z = 161.0962
[M+H] + , when tCA was used, and of m/z = 168.
[M+H]
+ when D 7 -tCA was used. Our previous work with in vivo experiments already proved that UP1 was derived by conversion of tCA (Gottardi et al. 2017a) . Using now D 7 -tCA further proved that the identified compound, UP1, incorporates part of tCA as it is possible to observe a mass shift of 7 by using D 7 -tCA. Most importantly, the suggested sum formula predicted for UP1 is C 11 H 13 O, [M+H] + (Table S2 , Supporting Information). Such formula could correspond to cinnamyl methyl ketone (C 11 H 12 O) (Fig. 1) . We, therefore, propose that cinnamyl methyl ketone is produced via dehydration of (2S,3R) 5-phenylpent-4-ene-2,3-diol (Fig. 1) . The intermediate (2S,3R) 5-phenylpent-4-ene-2,3-diol is a valuable precursor used for synthesising drugs and pheromone, in particular the chemotherapic drug daunomycin, used in the treatment of leukaemia (Fronza et al. 1982; Fuganti 1990; Miyakoshi et al. 2016 ). Our findings demonstrate that the pathway leading to cinnamyl methyl ketone is present in our engineered yeast; therefore, the possibility of producing other valuable intermediates of the pathway is open.
CONCLUSIONS
Focusing on the aromatic amino acid biosynthesis pathway, we could rationally improve tCA and HcinOH production, two fine chemicals with relevant applications in the cosmetic industry. Moreover, we proved the suitability of two new heterologous enzymes, not yet exploited in yeast: a bacterial PAL, PlStlA, and the UDP-glucose:cinnamate glucosyltransferase, FaGT2, from strawberry. In particular, production of cinnamoyl-D-glucose by FaGT2 unlocks the possibility to improve the production of tCA as an end product, due to the possibility that glucosides cause lower toxicity (Hansen et al. 2009 ). Parallel to the metabolic route for the production of HcinOH, we also propose a different one, based on previous results obtained by Miyakoshi et al. (2016) . Our findings suggest that one intermediate of the pathway, cinALD, not only is further reduced to HcinOH, but is also ligated to active acetaldehyde by Pdcmediated carboligation, resulting in the final production of cinnamyl methyl ketone via two additional enzymatic steps. Further analyses, such as nuclear magnetic resonance (NMR) studies, would help to clearly identify the unknown by-product UP1 and support our findings.
